Arvinas Inc (ARVN) Stock Price & News

ARVN:NASDAQ

Arvinas Inc

$7.51

+0.81%

(+0.060) 1D

$7.51

0.00% (0.00)

After hours

Closed: Oct 8, 4:00:00 PM GMT-4 · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for ARVN...

Open

$7.36

High

$7.55

Low

$7.24

Mkt. cap

491.05M

Avg. vol.

788.24K

Volume

0.00

P/E ratio

46.83

52-wk high

$14.51

52-wk low

$6.97

EPS

$0.16

Beta

1.81

Shares outstanding

65.39M

No. of employees

246

Open

$7.36

High

$7.55

Low

$7.24

Mkt. cap

491.05M

Avg. vol.

788.24K

Volume

0.00

P/E ratio

46.83

52-wk high

$14.51

52-wk low

$6.97

EPS

$0.16

Beta

1.81

Shares outstanding

65.39M

No. of employees

246

Related stocks

JANX

Janux Therapeutics Inc

$18.50

+3.24%

DYN

Dyne Therapeutics, Inc

$16.37

+2.50%

AUTL

Autolus Therapeutics PLC

$1.77

-2.21%

ARWR

Arrowhead Pharmaceuticals Inc

$60.74

-1.20%

News stories

From web sources and news partners

MarketBeat

21 hours ago

Arvinas, Inc. (NASDAQ:ARVN) Stock Has Average Price Target of $14.55

Yahoo Finance

1 day ago

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

About Arvinas Inc

CEO-

Employees246

Founded2013

HeadquartersNew Haven, Connecticut, United States

SectorPharmaceutical industry

Websitearvinas.com

Analyst	Recommendation	Action	Price target	Projected	Date
Tazeen Ahmad Bank of America Securities	Hold	Maintained	$16.00	+113%	10/07/2026
Robert Driscoll Wedbush	Hold	Maintained	$12.00	+59.8%	10/08/2026
Edward Tenthoff Piper Sandler	Buy	Reiterated	$20.00	+166.3%	09/14/2026
Srikripa Devarakonda Truist Financial	Hold	Reiterated	$8.68	+15.6%	08/10/2026
Terence Flynn Morgan Stanley	Hold	Reiterated	$10.00	+33.2%	08/10/2026
Jonathan Miller Evercore ISI	Buy	Reiterated	$14.00	+86.4%	08/10/2026
Yigal Nochomovitz Citi	Buy	Maintained	$21.00	+179.6%	08/10/2026
Andrew Fein H.C. Wainwright	Buy	Maintained	$18.00	+139.7%	08/05/2026
Etzer Darout Barclays	Buy	Maintained	$20.00	+166.3%	08/05/2026
Nicholas Lorusso TD Cowen	Hold	Maintained	-	-	08/04/2026
Derek Archila Wells Fargo	Hold	Downgraded	$11.00	+46.5%	08/05/2026
Unknown Analyst Leerink Partners	Hold	Maintained	$9.00	+19.8%	05/15/2026
Paul Choi Goldman Sachs	Sell	Maintained	$6.00	-20.1%	05/12/2026
Jeet Mukherjee BTIG	Buy	Reiterated	$18.00	+139.7%	05/13/2026
Tyler Van Buren TD Cowen	Hold	Maintained	-	-	05/12/2026
Unknown Analyst Guggenheim	Buy	Maintained	$15.00	+99.7%	05/01/2026
Matthew Biegler Oppenheimer	Hold	Reiterated	-	-	02/26/2026
Sudan Loganathan Stephens	Buy	Maintained	$18.00	+139.7%	02/25/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	41.90M	9.50M	15.60M	249.70M
Cost of goods sold	-	-	60.00M	9.00M
Cost of revenue	-	-	60.00M	9.00M
Research and development expenses	64.30M	59.80M	-	52.30M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	21.60M	21.40M	18.80M	22.70M
Operating expense	85.90M	81.20M	18.80M	75.00M
Total operating expenses	85.90M	81.20M	78.80M	84.00M
Operating income	-44.00M	-71.70M	-63.20M	165.70M
Other non operating income	-	2.40M	-100.00K	-
EBT including unusual items	-34.80M	-67.20M	-57.50M	169.60M
EBT excluding unusual items	-35.00M	-61.90M	-56.90M	171.20M
Income tax expense	300.00K	200.00K	100.00K	200.00K
Effective tax rate	-0.86%	-0.30%	-0.17%	0.12%
Other operating expenses	-	-	-	-
Net income	-35.10M	-67.40M	-57.60M	169.40M
Net profit margin	-83.77%	-709.47%	-369.23%	67.84%
Earnings per share	-0.48	-1.10	-0.90	2.58
Interest and investment income	9.00M	7.40M	6.40M	5.50M
Interest expense	-	-	-	-
Net interest expenses	9.00M	7.40M	6.40M	5.50M
Depreciation and amortization charges	-	-	-	-
EBITDA	-43.20M	-71.00M	-62.50M	166.40M
Gain or loss from assets sale	-	-	-	-

Ask anything